Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease

Approximately 15–20% of patients with Kawasaki disease (KD) are not responsive to high-dose intravenous gammaglobulin (IVIG). We have previously reported a predictive method for identifying IVIG-non-responsive patients (high-risk KD patients). We determined the safety and effectiveness of pulse meth...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pediatrics 2009-02, Vol.168 (2), p.181-185
Hauptverfasser:	Okada, Keiko, Hara, Junichi, Maki, Ichiro, Miki, Kazunori, Matsuzaki, Kouji, Matsuoka, Taro, Yamamoto, Takehisa, Nishigaki, Toshinori, Kurotobi, Syunji, Sano, Tetsuya
Format:	Artikel
Sprache:	eng
Schlagworte:	Aspartate Aminotransferases - blood Bilirubin - blood Biological and medical sciences C-Reactive Protein - metabolism Cardiology. Vascular system Cardiovascular disease Child, Preschool Coronary Artery Disease - diagnosis Coronary Artery Disease - drug therapy Coronary Artery Disease - enzymology Coronary heart disease Coronary vessels Dose-Response Relationship, Drug Drug Therapy, Combination Female Fever gamma-Globulins - administration & dosage General aspects Heart Heparin - administration & dosage Humans Infant Infusions, Intravenous Kawasaki disease Male Medical sciences Medicine Medicine & Public Health Methylprednisolone - administration & dosage Mucocutaneous Lymph Node Syndrome - diagnosis Mucocutaneous Lymph Node Syndrome - drug therapy Mucocutaneous Lymph Node Syndrome - enzymology Original Paper Patients Pediatrics Proteins Pulse Therapy, Drug Risk Factors Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Standard scores Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!